Innoviz director reports 234,329 shares in Form 3

Innoviz Technologies Ltd. director Maor Shenaar Ronit filed an initial Form 3 reporting beneficial ownership of 234,329 ordinary shares.

Rhea-AI Filing Summary

Innoviz Technologies Ltd. director Maor Shenaar Ronit filed an initial Form 3 reporting beneficial ownership of 234,329 ordinary shares. This total includes 107,083 ordinary shares issuable upon vesting of restricted share units granted on May 13, 2025, which vest on April 5, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Maor Shenaar Ronit

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 234,329 shares (Direct)

Footnotes (1)

1. F1. Includes 107,083 ordinary shares issuable upon vesting of restricted share units (RSUs) granted on May 13, 2025. The RSUs vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Innoviz Technologies (INVZ) director report in this Form 3?

The Form 3 shows director Maor Shenaar Ronit reporting beneficial ownership of 234,329 ordinary shares of Innoviz Technologies Ltd., including both currently held shares and shares tied to restricted share units that will vest in the future.

How many Innoviz Technologies (INVZ) shares does the director beneficially own?

The director reports beneficial ownership of 234,329 ordinary shares. This figure combines existing holdings with 107,083 ordinary shares that may be issued upon vesting of restricted share units, reflecting the director’s total reported equity exposure.

What restricted share units (RSUs) are disclosed for Innoviz Technologies (INVZ)?

The filing notes 107,083 ordinary shares issuable upon vesting of RSUs granted on May 13, 2025. Each RSU represents a contingent right to receive one ordinary share, with no exercise price applicable to these awards.

When do the Innoviz Technologies (INVZ) RSUs reported in this Form 3 vest?

The RSUs disclosed in the Form 3 vest on April 5, 2026. Once vested, each of the 107,083 restricted share units converts into one ordinary share of Innoviz Technologies Ltd., increasing the director’s actual share holdings at that time.

Is there any buy or sell transaction in this Innoviz Technologies (INVZ) Form 3?

This Form 3 is an initial statement of beneficial ownership and does not report any specific buy or sell transaction. It simply lists the director’s total reported holdings, including shares tied to future vesting of restricted share units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 06:26 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Maor Shenaar Ronit

(Last) (First) (Middle)

C/O INNOVIZ TECHNOLOGIES LTD.

5 URI ARIAV STREET, BUILDING C

(Street)

ROSH HA'AIN 4809202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Innoviz Technologies Ltd. [ INVZ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	234,329(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 107,083 ordinary shares issuable upon vesting of restricted share units (RSUs) granted on May 13, 2025. The RSUs vest on April 5, 2026. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

Remarks:

[Exhibit 24 - Power of Attorney.]

	/s/ Dafna Raz - Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)